Michael F. Cola is listed as an executive officer and director on 5 SEC Form D filings by 2 issuers between Apr 2010 and Oct 2017: Aevi Genomic Medicine, Inc. (Wayne, PA — biotechnology — 2015–2017; $28M reported sold to 88 investors) and NUPATHE INC. (Conshohocken, PA — pharmaceuticals — 2010–2012; $28M reported sold to 20 investors).
What this means 2 separate companies raised money with this person listed as executive officer and director, over about 7 years. Across those companies the filings report $56M sold in total.
Listed alongside Keith A. Goldan (3 shared filings), Terri B. Sebree (3 shared filings), Alastair Clemow (2 shared filings), Barbara Duncan (2 shared filings), Eugene Bauer (2 shared filings) and 25 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Michael. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 5 public filings for Michael F. Cola and found 8 differences: No amendment in the last 12 months on an offering that may still be open; Michael F. Cola is written 2 different ways on the filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.